SOLICITATION NOTICE
A -- NIH TETRAMER CORE FACILITY
- Notice Date
- 9/11/2018
- Notice Type
- Presolicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 5601 Fishers Lane, 3rd Floor, MSC 9821, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- RFP-NIAID-DAIT-NIH-AI-201800017
- Point of Contact
- Maribel Miranda, Phone: 240-669-5139, Tom Bahrami, Phone: 2406695147
- E-Mail Address
-
maribel.miranda@nih.gov, bahramit@niaid.nih.gov
(maribel.miranda@nih.gov, bahramit@niaid.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Allergy, Immunology and Transplantation, has a requirement for continuing the NIH Tetramer Core Facility contract. Description The scope of activities to be conducted by the NIH Tetramer Core Facility Contractor include synthesis and distribution of soluble MHC-peptide tetramer and related reagents to the global research community, and performance of research and development to improve tetramer technologies and increase the types of products available to the biomedical research community. Such reagents include, but are not limited to, mouse, non-human primate, human, and other mammalian MHC class I monomers and tetramers; custom and pre-made mouse, non-human primate, human, and other mammalian class II tetramers; non-classical MHC TL, Qa-1, MR1, and mammalian CD1 monomers and tetramers; CD1d and other MHC ligands; and fluorophores for tetramer labeling/detection. It is anticipated that one IDIQ type contract will be awarded for a period of 7 years beginning approximately December 2019, with an anticipated annual total effort of approximately 10.8 FTEs associated with Task Area A. Any responsible offeror may submit a proposal which will be considered by the Agency. This RFP will be available electronically on/about September 26, 2018 and may be accessed through FedBizOpps http://www.fedbizopps.gov/. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. For this solicitation, the NIAID requires proposals to be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) website. Submission of proposals by facsimile or e-mail is not acceptable. For directions on using eCPS, go to the website https://ecps.niaid.nih.gov and then click on "How to Submit."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIAID-DAIT-NIH-AI-201800017/listing.html)
- Record
- SN05084436-W 20180913/180911231545-f0df53bcfef9d95caa14c7e76156365b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |